This Applied Materials Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Barclays analyst Henning Cosman upgraded the rating for Ferrari N.V. RACE from Equal-Weight to Overweight. Ferrari shares closed at $426.82 on Thursday. See how other analysts view this stock.
  • Jefferies analyst Blayne Curtis upgraded Applied Materials, Inc. AMAT from Hold to Buy and announced a $195 price target. Applied Materials shares closed at $147.68 on Thursday. See how other analysts view this stock.
  • BMO Capital analyst Keith Bachman upgraded the rating for Check Point Software Technologies Ltd. CHKP from Market Perform to Outperform and raised the price target from $245 to $275. Check Point Software shares closed at $231.31 on Thursday. See how other analysts view this stock.
  • Goldman Sachs analyst Caitlin Burrows upgraded Tanger Inc. SKT from Neutral to Buy and boosted the price target from $39 to $40. Tanger shares closed at $32.86 on Thursday. See how other analysts view this stock.
  • B of A Securities analyst Alec Stranahan upgraded the rating for Beam Therapeutics Inc. BEAM from Neutral to Buy and maintained the price target of $42. Beam Therapeutics shares closed at $22.19 on Thursday.  See how other analysts view this stock.

Considering buying AMAT stock? Here’s what analysts think:

Read This Next:

Photo: Shutterstock

AMAT Logo
AMATApplied Materials Inc
$129.000.03%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
20.10
Growth
48.11
Quality
81.84
Value
50.70
Price Trend
Short
Medium
Long
Got Questions? Ask
Which luxury car manufacturers may benefit from Ferrari's upgrade?
How could semiconductor companies react to AMAT's bullish outlook?
What does Check Point's upgrade mean for cybersecurity firms?
Could Tanger's upgrade influence retail real estate investments?
How might Beam Therapeutics' rating change affect biotech stocks?
Which investment funds could profit from the upgrades mentioned?
What impact might AMAT's price target have on technology sector investments?
How will analyst upgrades shift market sentiments for these stocks?
Who else in the luxury market could be affected by Ferrari's performance?
Which emerging tech stocks should be on investors' radars post-upgrades?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: